Cronos (CRON) Cash from Financing Activities (2019 - 2026)

Cronos' (CRON) quarterly Cash from Financing Activities came in at -$18.3 million in Q1 2026, down 523.48% year-on-year from $4.3 million in Q1 2025, and down 146.1% quarter-over-quarter from -$7.4 million in Q4 2025.

Cronos (CRON) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Cronos' Cash from Financing Activities history runs 8 years deep, the most recent figure standing at -$18.3 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 523.48% year-over-year to -$18.3 million in Q1 2026; TTM through Mar 2026 was -$35.2 million, a 902.36% decrease from a year earlier, with the FY2025 full-year figure at -$19.9 million, down 1516.98% from the prior year.
  • Cash from Financing Activities fell to -$18.3 million in Q1 2026 per CRON's latest filing, from -$7.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$13000.0 in Q3 2024 and bottomed at -$18.3 million in Q1 2026.
  • The 5-year median for Cash from Financing Activities is -$620000.0 (2022), against an average of -$2.5 million.
  • Across the five-year window, Cash from Financing Activities surged 97.52% in 2023 and plunged 14253.85% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$620000.0 in 2022, then soared by 64.84% to -$218000.0 in 2023, then slumped by 43.58% to -$313000.0 in 2024, then sank by 2271.57% to -$7.4 million in 2025, then tumbled by 146.1% to -$18.3 million in 2026.
  • Per Business Quant, the three latest CRON Cash from Financing Activities figures stand at -$18.3 million (Q1 2026), -$7.4 million (Q4 2025), and -$1.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn -18.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.27 Mn
Mar 31, 2026 -18.27 Mn
Dec 31, 2025 -7.42 Mn
Dec 31, 2025 -7.42 Mn
Sep 30, 2025 -1.87 Mn
Sep 30, 2025 -1.87 Mn
Jun 30, 2025 -7.69 Mn
Jun 30, 2025 -7.69 Mn
Mar 31, 2025 -2.93 Mn
Mar 31, 2025 -2.93 Mn
Dec 31, 2024 -313,000.00
Dec 31, 2024 -313,000.00
Sep 30, 2024 -13,000.00
Sep 30, 2024 -13,000.00
Jun 30, 2024 -260,000.00
Jun 30, 2024 -260,000.00
Mar 31, 2024 -645,000.00
Mar 31, 2024 -645,000.00
Dec 31, 2023 -218,000.00
Dec 31, 2023 -218,000.00